Analgesia During Removal of Nasal Pack After Nasal Surgery
Conditions
Brief summary
the Investigators aim to study the effect of fentanyl with topical levobupivacaine with nasal packing in endoscopic nasal surgery
Interventions
DRUGFentanyl + Topical Levobupivacaine
in nasal packing
DRUGlevobupivacaine
in nasal packing
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. All patients in the age of 18-60 year 2. ASA I-II 3. Undergoing elective nasal endoscopic surgery \-
Exclusion criteria
1. Patients will also be excluded if any perioperative cardiovascular or respiratory event occurred which the anaesthetist with clinical responsibility for the patient thought would make the study intervention clinically unacceptable. 2. unsatisfactory preoperative peripheral arterial oxygen saturation. 3. Unsatisfactory preoperative hemoglobin level. 4. Neurological or psychiatric disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postoperative pain by visual analoge score | 24 houres postoperative pain assessment | assessment of pain on removal of nasal packing after endoscopic nasal surgery by VAS score. The Visual Analogue Scale (VAS) (0, no discomfort and no pain; 10, a high level of discomfort and maximum pain) |
Countries
Egypt
Contacts
Primary ContactMarwa M Abdelrady
Backup Contactwesam A Nashat
Outcome results
None listed